# Exploratory Efficacy of N-Acetylcysteine in Patients With History of COVID-19

> **NCT05736887** · PHASE2 · UNKNOWN · sponsor: **Fondazione Policlinico Universitario Agostino Gemelli IRCCS** · enrollment: 80 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** N-Acetylcysteine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05736887
- **Lead sponsor:** Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-24
- **Primary completion:** 2023-01-16
- **Final completion:** 2023-06
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2023-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05736887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05736887, "Exploratory Efficacy of N-Acetylcysteine in Patients With History of COVID-19". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05736887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
